Aptose Biosciences Inc. (APTO)
NASDAQ: APTO
· Real-Time Price · USD
1.71
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
Aptose Biosciences Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.3 | -5.97 | -2.48 | -4.31 | -6.97 | -10.56 | -11.92 | -15.35 | -16.24 | -20.1 | -21.24 | -24.23 | -39.56 | -18.53 | -64.24 | -82.31 | -123.07 |
PEG Ratio | -0.00 | 0.08 | 0.54 | 0.18 | 1.57 | -4.64 | 0.53 | -6.82 | -0.44 | -10.65 | 2.81 | 2.23 | 0.75 | -0.16 | 4.05 | 4.88 | -12.21 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 528.46 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -0.91 | -8.33 | -7.56 | -57.5 | 1.96K | -174.02 | 70.16 | 62.95 | 34.19 | 21.30 | 17.74 | 18.45 | 27.83 | 24.29 | 32.84 | 45.17 | 73.01 |
P/FCF Ratio | -2.4 | -4.69 | -6.65 | -21.65 | -22.95 | -54.52 | -51.78 | -64.13 | -78.62 | -92.94 | -119.01 | -144.8 | -188.35 | -112.3 | -353.4 | -502.52 | -768.59 |
P/OCF Ratio | -2.4 | -4.69 | -6.65 | -21.65 | -22.84 | -54.52 | -51.78 | -64.27 | -78.62 | -92.94 | -119.01 | -145.3 | -188.35 | -112.4 | -361.33 | -502.52 | -769.85 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -9.69 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -1.22 | -2.34 | -1.17 | -0.38 | 6.71 | -0.35 | 0.14 | 0.09 | 0.05 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 1.10 | 2.14 | 1.05 | 0.80 | 0.97 | 0.78 | 1.59 | 2.11 | 3.05 | 4.03 | 5.53 | 6.89 | 9.83 | 10.00 | 11.60 | 13.67 | 21.26 |
Current Ratio | 1.10 | 2.14 | 1.05 | 0.80 | 0.97 | 0.78 | 1.59 | 2.11 | 3.05 | 4.03 | 5.53 | 6.89 | 9.83 | 10.00 | 11.60 | 13.67 | 21.26 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.07 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -65.01 | -10.57 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | 0.75 | 0.35 | 0.76 | 3.33 | -70.36 | 4.12 | -1.47 | -1.02 | -0.53 | -0.26 | -0.21 | -0.19 | -0.18 | -0.33 | -0.13 | -0.14 | -0.15 |
Return on Assets | -0.74 | -0.16 | -0.64 | -0.66 | -0.75 | -0.92 | -0.55 | -0.53 | -0.35 | -0.2 | -0.17 | -0.16 | -0.16 | -0.29 | -0.12 | -0.13 | -0.14 |
Return on Invested Capital | -3.43 | -0.36 | -4.39 | 5.41 | -9.24 | 6.43 | -1.29 | -0.96 | -0.52 | -0.27 | -0.21 | -0.19 | -0.17 | -0.33 | -0.13 | -0.14 | -0.15 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 0.63 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -12.51 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -12.51 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -12.69 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -12.58 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |